FDA Drug Recalls

Recalls / Class III

Class IIID-0249-2018

Product

Clobetasol Propionate Cream USP, 0.05% 60 g tube, Rx only Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761 Dist. by : Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532 UPC 351672125837 NDC 51672-1258-3

Brand name
Clobetasol Propionate
Generic name
Clobetasol Propionate
Active ingredient
Clobetasol Propionate
Route
Topical
NDCs
51672-1258, 51672-1294, 51672-1259
FDA application
ANDA074249
Affected lot / code info
Lot 311235, exp Sept 2018

Why it was recalled

Failed Content Uniformity Specifications

Recalling firm

Firm
Taro Pharmaceuticals U.S.A., Inc.
Manufacturer
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3 Skyline Dr, Hawthorne, New York 10532-2174

Distribution

Quantity
27,792 tubes
Distribution pattern
Nationwide

Timeline

Recall initiated
2017-12-21
FDA classified
2018-02-01
Posted by FDA
2018-02-07
Terminated
2020-09-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0249-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Clobetasol Propionate · FDA Drug Recalls